Apply Now: Pfizer Fellowship Grant Program (United States)

Deadline: 01-Apr-2026

The Pfizer Fellowship Grant Program 2026 provides up to $80,000 in one-year salary support for inflammatory bowel disease (IBD) fellows at accredited U.S. academic institutions. Funding is awarded to institutions—not individuals—to strengthen the IBD workforce, advance health equity, and improve standards of care. The application deadline is 01 April 2026, with projects expected to start in July 2026 or later.

Program Overview

The Pfizer Fellowship Grant Program supports inflammatory bowel disease (IBD) fellowship programs in the United States. The goal is to:

• Strengthen the IBD workforce

• Advance healthcare equity

• Improve quality of care

• Support structured mentorship and independent research

Funding is provided directly to accredited U.S. academic institutions to support one fellow for a one-year period.

What Is Inflammatory Bowel Disease (IBD)?

IBD refers to chronic inflammatory conditions of the gastrointestinal tract, primarily:

• Crohn’s disease

• Ulcerative colitis

IBD requires specialized clinical expertise, multidisciplinary care, and ongoing research to improve patient outcomes. This grant aims to expand the pipeline of trained IBD specialists, especially in underserved regions.

Funding Details

Maximum Funding: Up to $80,000
Funding Duration: 1 year
Start Date: July 2026 or later
Project End Date: One year after start date

Allowable Costs

• Fellow salary

• Fellow benefits

Not Allowed

• Overhead or indirect costs

• Patient care billing for grant-supported time

• Basic science research

• Study or evaluation of pharmaceutical products

• Activities benefiting Pfizer’s business or assets

Institutions must disclose any additional financial support sources.

Program Priorities and Focus Areas

Applications should align with one or more of the following priorities:

• Healthcare equity initiatives

• Addressing healthcare disparities

• Social determinants of health

• Workforce development in underserved regions

• Clinical practice improvement

• Independent observational and outcomes research

• Education and mentorship

• Diversity and inclusion in IBD care

• Use of screening tools to improve patient health

• Advancing IBD care through:

  • Intestinal ultrasound (IUS)

  • AI-assisted endoscopy

  • Machine learning applications

Preference is given to:

• New IBD fellowship programs

• Institutions in states with fewer IBD fellowships

• Programs serving underserved populations

Who Is Eligible?

Eligible Institutions

Applicants must be:

• U.S.-based accredited academic institutions

• Offering structured IBD fellowship programs

• Providing independent research opportunities

• Demonstrating strong mentorship frameworks

Clinical training may be included, but grant-funded time cannot be billed as patient care.

Eligible Fellows (Institution-Supported Candidates)

Fellows supported under this grant must:

• Hold an M.D. or equivalent degree

• Meet U.S. work authorization requirements

• Be recent internal medicine graduates
  OR

• Be advanced GI fellows pursuing IBD specialization

Research and Fellowship Requirements

Funded fellowships must:

• Include structured mentorship

• Provide meaningful research training

• Focus on independent research

• Avoid pharmaceutical product evaluation

• Avoid basic science research

Programs must demonstrate the capacity to support fellows pursuing long-term careers in IBD care.

Why This Grant Matters

This fellowship program addresses critical workforce shortages in IBD care across the United States.

It supports:

• Expansion of specialized IBD training

• Equitable access to advanced GI care

• Workforce development in underserved states

• Integration of AI and machine learning in gastroenterology

• Improved patient outcomes through innovative screening tools

By investing in training and mentorship, the program contributes to long-term improvements in IBD treatment and care delivery.

How to Apply (Step-by-Step Guide)

Step 1: Confirm Institutional Eligibility

Ensure your institution:

• Is accredited and U.S.-based

• Offers a structured IBD fellowship program

• Provides independent research opportunities

• Can demonstrate strong mentorship support

Step 2: Develop Fellowship Proposal

Your proposal should clearly outline:

• Fellowship goals and objectives

• Population health relevance

• Patient care experience components

• Mentorship structure

• Research training framework

• Institutional resources

Step 3: Ensure Compliance

Confirm that:

• Research is independent

• No pharmaceutical product evaluation is included

• No basic science research is proposed

• Grant-funded time is not billed as patient care

Step 4: Submit Application

Submission Deadline: 01 April 2026

Selected institutions will receive email notification following review. Clarifications may be requested during evaluation.

Review and Selection Criteria

Applications are evaluated by an expert review panel using criteria such as:

• Fellowship program goals

• Demonstrated medical need

• Relevance to population health

• Quality of mentorship

• Patient care experience

• Training opportunities

• Institutional infrastructure and support

Award notifications are anticipated in May 2026.

Common Mistakes to Avoid

• Including indirect or overhead costs

• Proposing pharmaceutical product studies

• Submitting basic science research proposals

• Failing to disclose additional funding sources

• Billing patient care services to grant-supported time

• Weak or undefined mentorship frameworks

Clear alignment with workforce development and equity priorities strengthens applications.

Frequently Asked Questions (FAQ)

1. Who receives the funding?

Funding is awarded directly to institutions, not individual fellows.

2. How much funding is available?

Up to $80,000 to support one fellow for one year.

3. Can overhead costs be included?

No. Indirect or overhead costs are not permitted.

4. What types of research are allowed?

Only independent observational and outcomes research. Basic science research and pharmaceutical product evaluation are not allowed.

5. Are new fellowship programs eligible?

Yes. Preference is given to new programs and those in underserved states.

6. When is the application deadline?

The deadline is 01 April 2026.

7. When do funded projects begin?

Projects are expected to begin in July 2026 or later and conclude one year after the start date.

Conclusion

The Pfizer Fellowship Grant Program 2026 offers targeted salary support to expand the IBD specialist workforce in the United States. By prioritizing health equity, mentorship, and innovative clinical approaches, the program strengthens long-term standards of care in inflammatory bowel disease.

Eligible institutions should prepare structured, equity-focused fellowship proposals and submit applications before 01 April 2026 to support the next generation of IBD specialists.

For more information, visit Pfizer.